What Is CJC-1295 / Ipamorelin?
If you're looking at growth hormone optimization without using synthetic HGH itself, this combination is the most commonly prescribed peptide stack in US clinics right now. CJC-1295 and ipamorelin work on different but complementary receptors to coax your pituitary gland into releasing more of your own growth hormone — in pulses that closely resemble your body's natural secretion pattern, rather than the flat pharmacological spike you'd get from exogenous HGH.
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH), the signal your hypothalamus sends when it wants your pituitary to produce GH. Ipamorelin is a growth hormone secretagogue (GHS) that works through the ghrelin receptor (GHSR-1a) — a separate pathway that amplifies the GH pulse. Using both together is the key point: one opens the door, the other pushes through it.
Neither peptide is FDA approved as a standalone drug, but both are legally available in the US through licensed compounding pharmacies by prescription. That puts them in a different category from purely investigational compounds — you can actually access this through a legitimate clinical pathway today.
CJC-1295 and ipamorelin work through two separate receptor pathways (GHRH receptor and ghrelin receptor) to produce GH pulses that mimic the body's natural pattern — a meaningful difference from synthetic HGH.